CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.

Hidalgo-Tenorio C, García-Aguilera M, Santos IL, Ruiz-Sancho A, Rivero A, López-Lirola A, Omar M, Romero A, Bernal E, Martinez O, López T, Sorni P, García-Ocaña P, Moreno S, Sanjoaquín I, Blanco JR, Garcia C.

Open source

DOI
10.1016/j.ijantimicag.2026.107909
Published
2026-07-06
Container
Int J Antimicrob Agents
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijantimicag.2026.107909,
  title = {CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.},
  author = {Hidalgo-Tenorio C and  García-Aguilera M and  Santos IL and  Ruiz-Sancho A and  Rivero A and  López-Lirola A and  Omar M and  Romero A and  Bernal E and  Martinez O and  López T and  Sorni P and  García-Ocaña P and  Moreno S and  Sanjoaquín I and  Blanco JR and  Garcia C.},
  year = {2026},
  journal = {Int J Antimicrob Agents},
  doi = {10.1016/j.ijantimicag.2026.107909},
  url = {https://doi.org/10.1016/j.ijantimicag.2026.107909}
}

RIS

TY  - JOUR
TI  - CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.
AU  - Hidalgo-Tenorio C
AU  -  García-Aguilera M
AU  -  Santos IL
AU  -  Ruiz-Sancho A
AU  -  Rivero A
AU  -  López-Lirola A
AU  -  Omar M
AU  -  Romero A
AU  -  Bernal E
AU  -  Martinez O
AU  -  López T
AU  -  Sorni P
AU  -  García-Ocaña P
AU  -  Moreno S
AU  -  Sanjoaquín I
AU  -  Blanco JR
AU  -  Garcia C.
PY  - 2026
JO  - Int J Antimicrob Agents
DO  - 10.1016/j.ijantimicag.2026.107909
UR  - https://doi.org/10.1016/j.ijantimicag.2026.107909
ER  - 

APA

C, H., M, G., IL, S., A, R., A, R., A, L., M, O., A, R., E, B., O, M., T, L., P, S., P, G., S, M., I, S., JR, B., & C., G. (2026). CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2026.107909

Source records